X0607 3 2026-09-19 0 0002029039 Nasus Pharma Ltd NSRX 0001713701 Elmaliah Oren true P.O. BOX 284 TEL-AVIV-YAFO L3 6100201 ISRAEL 0 1 0 0 Interim CFO Share options (right to buy) 1.2264 2020-06-13 2029-11-28 Ordinary Shares 24680 D Share options (right to buy) 6.0462 2025-01-17 2035-01-17 Ordinary Shares 27460 D Options to purchase 24,680 ordinary shares of the Issuer, no par value ("Ordinary Shares") were granted on November 28, 2019. As of September 18, 2026, 24,680 options remain outstanding, all of which are vested and exercisable, at an exercise price of $1.2264 per share, expiring November 28, 2029. Options to purchase 27,460 Ordinary Shares were granted on January 17, 2025, with the total grant vesting in equal quarterly installments of 8.33% commencing on January 17, 2025. As of September 18, 2026, 13,840 are vested and exercisable, at an exercise price of $6.0462 per share, expiring January 17, 2035. /s/ Oren Elmaliah 2026-09-23